期刊文献+

伊托必利与埃索美拉唑联用治疗反流性食管炎的疗效分析 被引量:6

下载PDF
导出
摘要 目的探讨伊托必利与埃索美拉唑联用治疗反流性食管炎的疗效分析。方法采用回顾性分析的方法,对我院收治的90例反流性食管炎患者分为治疗组和对照组A、B各30例。给予治疗组患者埃索美拉唑20mg,每日2次,伊托必利片50mg,每日3次;给予对照组A患者埃索美拉唑20mg,每日2次;给予对照组B患者伊托必利片50mg,每日3次,疗程8周。结果分析3组反流性食管炎临床疗效,治疗组总有效率100%,对照组A总有效率76%,对照组B总有效率73%,3组两两比较差异有统计学意义(P<0.05);反流性食管炎胃镜表现治疗组有效率93%,对照组A有效率63%,对照组B有效率63%,3组两两比较差异有统计学意义(P<0.05);反流性食管炎治疗效果的Ridit分析差别有统计学意义(P<0.05)。结论伊托必利与埃索美拉唑联用治疗反流性食管炎治疗效率高、不良反应小、优于单独用药,值得临床推广。
作者 秦波
出处 《海峡药学》 2013年第2期178-180,共3页 Strait Pharmaceutical Journal
  • 相关文献

参考文献9

二级参考文献80

共引文献147

同被引文献55

  • 1梁华荣,余伟,刘飞雄,王三兵.雷贝拉唑联合伊托必利治疗胃食管反流病疗效观察[J].中华临床医师杂志(电子版),2011,5(24):7402-7404. 被引量:7
  • 2陆星华,张泰昌.反流性食管炎诊断及治疗指南(2003年)[J].中华消化内镜杂志,2004,21(4):221-222. 被引量:844
  • 3候建南,常伟宗,尚杰.奥美拉唑、伊托必利和铝镁加联合治疗反流性食管炎的疗效观察[J].中国现代医药,2010,27(4):154-155.
  • 4Kinoshita Y,Miwa H,Kasugai K. Efficacy of esomeprazole compared with omeprazole in reflux esophagitis patients-a phase Ⅲ,multicenter,randomized,double-blind,parallel-group trial[J].Nihon Shokakibyo Gakkai Zasshi,2013,(2):234-242.
  • 5Kinoshita Y,Hongo M,Japan 'TWICE Study' Group. Efficacy of twice daily rabeprazole for reflux esophagitis patients refractory to standard once daily administration of PPI:the Japan-based TWICE study[J].The American Journal of Gastroenterology,2012,(4):522-530.
  • 6Park JH,Park H,Lee DH. A randomized double-blinded clinical trial to assess the efficacy and cost effectiveness of omeprazole compared to rabeprazole in the maintenance therapy of patients with gastroesophageal reflux disease[J].J Neurogastroenterol Motil,2013,(2):219-226.
  • 7lida H,Inamori M,Fujii T. Early effect of oral administration of om eprazole with mosapride as compared with those of omeprazole alone on the intragastric pH[J].{H}BMC Gastroenterology,2012,(12):25.
  • 8Kallel L,Bibani N,Fekih M. Metabolic syndrome is associated with gastroesophageal reflux disease based on a 24-hour ambulatory pH monitoring[J].Diseases of the Esophagus,2011,(3):153-159.
  • 9Nagahara A,Hojo M,Asaoka D. Clinical feature of asymptomatic reflux esophagitis in patients who underwent upper gastrointestinal endoscopy[J].{H}Journal of Gastroenterology,2012,(Suppl 3):53-57.
  • 10Keller G A,Czerniuk P,Bertuola R. Relative bioavailability of a 5mg mosapride/10 mg rabeprazole fixed dose combination tablet versus separate single tablets in healthy volunteers:a single-dose randomized open-label crossover study[J].{H}CURRENT MEDICAL RESEARCH AND OPINION,2011,(11):2203-2211.

引证文献6

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部